Cargando…
Survival outcomes in locally advanced dMMR rectal cancer: surgery plus adjunctive treatment vs. surgery alone
BACKGROUND: Recent studies have shown that deficient mismatch repair (dMMR) rectal cancer may be related to treatment resistance, resulting in a worse prognosis than proficient MMR (pMMR) rectal cancer. The purpose of this study was to explore whether surgery plus other treatments (radiotherapy and...
Autores principales: | Ni, Kemin, Zhan, Yixiang, Liu, Zhaoce, Yuan, Zhen, Wang, Shuyuan, Zhao, Xuan-zhu, Ping, Hangyu, Liu, Yaohong, Wang, Wanting, Yan, Suying, Xin, Ran, Han, Qiurong, Zhang, Qinghuai, Li, Guoxun, Zhang, Xipeng, Wang, Guihua, Zhang, Zili, Ma, Hong, Zhang, Chunze |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10588073/ https://www.ncbi.nlm.nih.gov/pubmed/37864137 http://dx.doi.org/10.1186/s12885-023-11525-7 |
Ejemplares similares
-
Effects of deficient mismatch repair on the prognosis of patients with stage II and stage III colon cancer during different postoperative periods
por: Zhang, Chunze, et al.
Publicado: (2022) -
Stage III deficient mismatch repair colon patients get greater benefit from earlier starting oxaliplatin-based chemotherapy regimen
por: Zhan, Yixiang, et al.
Publicado: (2023) -
The stool syndecan2 methylation test is more robust than blood tests for methylated septin9, CEA, CA19-9 and CA724: a diagnostic test for the early detection of colorectal neoplasms
por: Zhan, Yixiang, et al.
Publicado: (2023) -
Circulating Methylated SEPT9 DNA Analyses to Predict Recurrence Risk and Adjuvant Chemotherapy Benefit in Stage II to III Colorectal Cancer
por: Yuan, Zhen, et al.
Publicado: (2022) -
Colonoscopy compliance and diagnostic yield in a large population-based colorectal cancer screening programme
por: Zhao, Xinzhu, et al.
Publicado: (2023)